Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PD-L1 is expressed on human platelets and is affected by immune checkpoint therapy.
Rolfes V, Idel C, Pries R, Plötze-Martin K, Habermann J, Gemoll T, Bohnet S, Latz E, Ribbat-Idel J, Franklin BS, Wollenberg B. Rolfes V, et al. Among authors: idel c. Oncotarget. 2018 Jun 8;9(44):27460-27470. doi: 10.18632/oncotarget.25446. eCollection 2018 Jun 8. Oncotarget. 2018. PMID: 29937998 Free PMC article.
A randomized trial (RAREST-01) comparing Mepitel® Film and standard care for prevention of radiation dermatitis in patients irradiated for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN).
Rades D, Narvaez CA, Splettstößer L, Dömer C, Setter C, Idel C, Ribbat-Idel J, Perner S, Bartscht T, Olbrich D, Schild SE, Carl J. Rades D, et al. Among authors: idel c. Radiother Oncol. 2019 Oct;139:79-82. doi: 10.1016/j.radonc.2019.07.023. Epub 2019 Aug 17. Radiother Oncol. 2019. PMID: 31431372 Clinical Trial.
EVI1 as a Marker for Lymph Node Metastasis in HNSCC.
Idel C, Ribbat-Idel J, Kuppler P, Krupar R, Offermann A, Vogel W, Rades D, Kirfel J, Wollenberg B, Perner S. Idel C, et al. Int J Mol Sci. 2020 Jan 28;21(3):854. doi: 10.3390/ijms21030854. Int J Mol Sci. 2020. PMID: 32013033 Free PMC article.
CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC.
Paulsen FO, Idel C, Ribbat-Idel J, Kuppler P, Klapper L, Rades D, Bruchhage KL, Wollenberg B, Brägelmann J, Perner S, Offermann A. Paulsen FO, et al. Among authors: idel c. Int J Mol Sci. 2020 Jul 31;21(15):5508. doi: 10.3390/ijms21155508. Int J Mol Sci. 2020. PMID: 32752128 Free PMC article.
NR2F6 as a Prognostic Biomarker in HNSCC.
Klapper L, Ribbat-Idel J, Kuppler P, Paulsen FO, Bruchhage KL, Rades D, Offermann A, Kirfel J, Wollenberg B, Idel C, Perner S. Klapper L, et al. Among authors: idel c. Int J Mol Sci. 2020 Aug 1;21(15):5527. doi: 10.3390/ijms21155527. Int J Mol Sci. 2020. PMID: 32752295 Free PMC article.
Recurrent HNSCC Harbor an Immunosuppressive Tumor Immune Microenvironment Suggesting Successful Tumor Immune Evasion.
Watermann C, Pasternack H, Idel C, Ribbat-Idel J, Brägelmann J, Kuppler P, Offermann A, Jonigk D, Kühnel MP, Schröck A, Dreyer E, Rosero C, Nathansen J, Dubrovska A, Tharun L, Kirfel J, Wollenberg B, Perner S, Krupar R. Watermann C, et al. Among authors: idel c. Clin Cancer Res. 2021 Jan 15;27(2):632-644. doi: 10.1158/1078-0432.CCR-20-0197. Epub 2020 Oct 27. Clin Cancer Res. 2021. PMID: 33109740
57 results